Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.23 USD | -2.73% | -4.85% | -13.37% |
10/05 | Pacira BioSciences Prices $250 Million Convertible Senior Notes Offering | MT |
08/05 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.37% | 1.36B | |
+39.22% | 731B | |
+32.17% | 586B | |
-7.85% | 348B | |
+15.48% | 319B | |
-0.12% | 273B | |
+13.36% | 235B | |
+7.43% | 202B | |
-7.12% | 203B | |
-3.37% | 158B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Transcript : Pacira BioSciences, Inc., Q1 2023 Earnings Call, May 03, 2023